Icosavax to Participate in the Upcoming Healthcare Conferences
28 févr. 2023 08h00 HE
|
Icosavax, Inc.
SEATTLE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
EnerSys CEO David M. Shaffer to Present at the Oppenheimer 17th Annual Industrial Growth Conference May 3, 2022
19 avr. 2022 16h15 HE
|
EnerSys
READING, Pa., April 19, 2022 (GLOBE NEWSWIRE) -- EnerSys (NYSE: ENS), the global leader in stored energy solutions for industrial applications, announced today that David M. Shaffer, President and...
Novan, Inc. to Present at Two Upcoming Investor Conferences
14 mars 2022 09h00 HE
|
Novan, Inc.
DURHAM, N.C., March 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...
Processa Pharmaceuticals CEO Dr. David Young To Present at the Oppenheimer 32nd Annual Healthcare Conference
10 mars 2022 08h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, March 10, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to...
aTyr Pharma to Present at Upcoming Investor Conferences in March
03 mars 2022 08h00 HE
|
aTyr Pharma, Inc.
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
Synlogic To Present at Upcoming Investor and Industry Conferences
24 févr. 2022 07h00 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Warrants
07 oct. 2021 16h05 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common stock...
ATTENTION HORIZON PRIVATE EQUITY III INVESTORS: Law Firm Dimond Kaplan & Rothstein, P.A. is Investigating Claims Against Oppenheimer for Customers Who Lost Money in Horizon Private Equity III Alleged Ponzi Scheme
23 sept. 2021 11h29 HE
|
Dimond Kaplan & Rothstein, P.A.
MIAMI and LOS ANGELES, Sept. 23, 2021 (GLOBE NEWSWIRE) -- National investment fraud law firm Dimond Kaplan & Rothstein, P.A. (“DKR”) (http://www.dkrpa.com) is investigating potential claims...
aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
16 sept. 2021 16h01 HE
|
aTyr Pharma, Inc.
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
Conformis, Inc. to Participate in Upcoming Investor Conferences
07 sept. 2021 17h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features a range of personalized knee and hip replacement products,...